PdMo nanoflowers for endogenous/exogenous-stimulated nanocatalytic therapy

Xinqiang Liang,Yanping Tang,Mekhrdod S. Kurboniyon,Danni Luo,Guiwan Tu,Pengle Xia,Shufang Ning,Litu Zhang,Chen Wang
DOI: https://doi.org/10.3389/fphar.2023.1324764
IF: 5.6
2023-12-07
Frontiers in Pharmacology
Abstract:The clinical application of reactive oxygen species (ROS)-mediated tumor treatment has been critically limited by inefficient ROS generation. Herein, we rationally synthesized and constructed the three-dimensional PdMo nanoflowers through a one-pot solvothermal reduction method for elaborately regulated peroxidase-like enzymatic activity and glutathione peroxidase-like enzymatic activity, to promote oxidation ROS evolvement and antioxidation glutathione depletion for achieving intensive ROS-mediated tumor therapy. The three-dimensional superstructure composed of two-dimensional nanosheet subunits can solve the issues by avoiding the appearance of tightly stacked crystalline nanostructures. Significantly, Mo is chosen as a second metal to alloy with Pd because of its more chemical valence and negative ionization energy than Pd for improved electron transfer efficiencies and enhanced enzyme-like activities. In addition, the photothermal effect generated by PdMo nanoflowers could also enhance its enzymatic activities. Thus, this work provides a promising paradigm for achieving highly ROS-mediated tumor therapeutic efficacy by regulating the multi-enzymatic activities of Pd-based nanoalloys.
pharmacology & pharmacy
What problem does this paper attempt to address?